| MeSH term | MeSH ID | Detail |
|---|---|---|
| Neurotoxicity Syndromes | D020258 | 34 associated lipids |
| Autoimmune Diseases of the Nervous System | D020274 | 1 associated lipids |
| Migraine with Aura | D020325 | 1 associated lipids |
| Hypertensive Encephalopathy | D020343 | 1 associated lipids |
| Paraneoplastic Syndromes, Nervous System | D020361 | 1 associated lipids |
| Osteoarthritis, Knee | D020370 | 13 associated lipids |
| Sciatic Neuropathy | D020426 | 13 associated lipids |
| Peroneal Neuropathies | D020427 | 1 associated lipids |
| Brain Infarction | D020520 | 17 associated lipids |
| Stroke | D020521 | 32 associated lipids |
| Nervous System Autoimmune Disease, Experimental | D020721 | 3 associated lipids |
| Parkinsonian Disorders | D020734 | 20 associated lipids |
| Intracranial Thrombosis | D020767 | 2 associated lipids |
| Central Nervous System Viral Diseases | D020805 | 1 associated lipids |
| Hypoxia-Ischemia, Brain | D020925 | 22 associated lipids |
| Neuroaspergillosis | D020953 | 2 associated lipids |
| Brachial Plexus Neuritis | D020968 | 2 associated lipids |
| Lacerations | D022125 | 1 associated lipids |
| Coronary Stenosis | D023921 | 6 associated lipids |
| Polyomavirus Infections | D027601 | 1 associated lipids |
| Pulmonary Disease, Chronic Obstructive | D029424 | 16 associated lipids |
| Denys-Drash Syndrome | D030321 | 1 associated lipids |
| Papillomavirus Infections | D030361 | 4 associated lipids |
| Hyperuricemia | D033461 | 4 associated lipids |
| Hypoalbuminemia | D034141 | 1 associated lipids |
| Mastocytosis, Cutaneous | D034701 | 1 associated lipids |
| Cholecystolithiasis | D041761 | 2 associated lipids |
| Intestinal Volvulus | D045822 | 1 associated lipids |
| Ileus | D045823 | 3 associated lipids |
| Coproporphyria, Hereditary | D046349 | 1 associated lipids |
| Protoporphyria, Erythropoietic | D046351 | 1 associated lipids |
| Colitis, Collagenous | D046729 | 1 associated lipids |
| Hepatic Insufficiency | D048550 | 1 associated lipids |
| Diabetes Complications | D048909 | 4 associated lipids |
| Dyslipidemias | D050171 | 7 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Granulomatosis, Orofacial | D051261 | 2 associated lipids |
| Lymphohistiocytosis, Hemophagocytic | D051359 | 1 associated lipids |
| Renal Insufficiency | D051437 | 8 associated lipids |
| Delayed Graft Function | D051799 | 2 associated lipids |
| Nocturia | D053158 | 1 associated lipids |
| Dysuria | D053159 | 1 associated lipids |
| Posterior Leukoencephalopathy Syndrome | D054038 | 1 associated lipids |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | D054198 | 10 associated lipids |
| Dendritic Cell Sarcoma, Interdigitating | D054739 | 1 associated lipids |
| Idiopathic Interstitial Pneumonias | D054988 | 1 associated lipids |
| Primary Graft Dysfunction | D055031 | 1 associated lipids |
| Failed Back Surgery Syndrome | D055111 | 3 associated lipids |
| Pancreatitis, Graft | D055589 | 1 associated lipids |
| Multiple Pulmonary Nodules | D055613 | 2 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Staruch MJ et al. | Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells. | 1998 | Cell. Immunol. | pmid:9878113 |
| Madsen JR et al. | Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. | 1998 | Exp. Neurol. | pmid:9878202 |
| He G et al. | Modified surgical model of paratopic small bowel transplantation in mice. | 1998 | J. Surg. Res. | pmid:9878312 |
| Trajković V et al. | Cyclosporin A inhibits activation of inducible nitric oxide synthase in C6 glioma cell line. | 1999 | Brain Res. | pmid:9878697 |
| Herzberg GZ et al. | The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. | 1998 | J. Heart Lung Transplant. | pmid:9883760 |
| Harrison S et al. | Stimulation of airway sensory nerves by cyclosporin A and FK506 in guinea-pig isolated bronchus. | 1998 | Br. J. Pharmacol. | pmid:9884067 |
| Fisher RA et al. | A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. | 1998 | Transplantation | pmid:9884248 |
| Solez K et al. | Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. | 1998 | Transplantation | pmid:9884269 |
| Chen YW et al. | Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506). | 1999 | Clin. Immunol. | pmid:9884362 |
| Yoshioka K et al. | Post-transplant diabetes with anti-glutamic acid decarboxylase antibody during tacrolimus therapy. | 1998 | Diabetes Res. Clin. Pract. | pmid:9886744 |
| Soda Y et al. | Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia/reperfusion of rat small intestine. | 1999 | Surgery | pmid:9889794 |
| Hamar P et al. | Coinhibition of immune and renin-angiotensin systems reduces the pace of glomerulosclerosis in the rat remnant kidney. | 1999 | J. Am. Soc. Nephrol. | pmid:9892170 |
| Reich K et al. | Topical tacrolimus for pyoderma gangrenosum. | 1998 | Br. J. Dermatol. | pmid:9892935 |
| Kobashigawa JA | Advances in immunosuppression for heart transplantation. | 1998 | Adv Card Surg | pmid:9917904 |
| Bochelen D et al. | Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. | 1999 | J. Pharmacol. Exp. Ther. | pmid:9918571 |
| Skuk D et al. | Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. | 1999 | Exp. Neurol. | pmid:9918701 |
| Gruessner AC and Sutherland DE | Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). | 1997 | Clin Transpl | pmid:9919390 |
| Odorico JS et al. | Advances in pancreas transplantation: the University of Wisconsin experience. | 1997 | Clin Transpl | pmid:9919400 |
| Katznelson S et al. | Clinical aspects of sensitization. | 1997 | Clin Transpl | pmid:9919412 |
| Lee RK et al. | Prostaglandin E2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants. | 1999 | J. Neurosci. | pmid:9920657 |